Opening Session Panel Discussion

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Mark J. Ratain, MD, and Daniel Goldstein, MD, on Value in Cancer Care: How the Paradigm Is Shifting

Mark J. Ratain, MD, of the University of Chicago, and Daniel Goldstein, MD, of the Rabin Medical Center, discuss the challenges of achieving cancer care value, evolution of the “more-is-better” philosophy when it comes to oncology drugs, and highlights of the First International Summit on Interventional Pharmacoeconomics.

Opportunities to Optimize Cancer Policies Panel Discussion

Sep

Today In Oncology

Opening Session Panel Discussion

Related Videos

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Mark J. Ratain, MD, and Daniel Goldstein, MD, on Value in Cancer Care: How the Paradigm Is Shifting

Opportunities to Optimize Cancer Policies Panel Discussion

Cancer-Induced Nerve Injury Identified as Driver of PD-1 Resistance Across Tumor Types

Study Finds Postapproval Cancer Trials Fell After Inflation Reduction Act

Incorporating Family Caregivers Into Shared Decision-Making for Patients With Cancer

Clear-Margin Diagnostic Excisional Biopsy May Adequately Treat Melanoma in Situ, Study Finds

Is TBI Associated With Malignant Brain Tumors